Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655811 · ClinicalTrials.gov registry record · Phase 4
Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00655811 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 40 participants.
The verdict
NCT00655811, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research is to study how people respond differently to capsaicin in different racial groups and the effect it has on your pain levels. Capsaicin is a natural product made from hot chili peppers that is useful for treating the itch symptoms of skin disease.
Interventions
- DRUG Capsaicin
- DRUG Placebo moisturizing cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655811
The ClinicalTrials.gov registry entry for NCT00655811 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Capsaicin is the first listed.
NCT00655811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655811 about?
NCT00655811 is a clinical study titled "Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects". The purpose of this research is to study how people respond differently to capsaicin in different racial groups and the effect it has on your pain levels. Capsaicin is a natural product made from hot chili peppers that is useful for treating the itch symptoms of skin disease.
What is the current status of trial NCT00655811?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2008-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00655811?
The interventions under investigation include: Capsaicin (DRUG), Placebo moisturizing cream (DRUG).
Who is sponsoring clinical trial NCT00655811?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.